Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial

JOURNAL ARTICLE published July 2016 in The Lancet Oncology

Authors: Jeffrey S Weber | Geoff Gibney | Ryan J Sullivan | Jeffrey A Sosman | Craig L Slingluff | Donald P Lawrence | Theodore F Logan | Lynn M Schuchter | Suresh Nair | Leslie Fecher | Elizabeth I Buchbinder | Elmer Berghorn | Mary Ruisi | George Kong | Joel Jiang | Christine Horak | F Stephen Hodi